SCOLR Pharma, Inc

(AMEX:DDD)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Operating revenue
Total Revenue 236 280 266 222
Operating Revenue 236 280 266 222
Adjustments To Revenue — — — —
Cost Of Sales -102 -105 -105 -105
Cost Of Sales With Depreciation — — — —
Gross Operating Profit 339 384 370 327
Operating Expenses
Research And Development Expenses 2,307 1,197 883 2,358
Selling General And Administrative Expenses 1,065 1,254 1,470 1,512
Advertising Expenses — — — —
Operating Income Before Depreciation -3,033 -2,067 -1,983 -3,543
Operating Income 848 -2,171 -2,088 -3,648
Depreciation 102 105 105 105
Depreciation Unreconciled — — — —
Amortization — — — —
Amortization Of Intangibles — — — —
Operating Income After Depreciation -3,135 -2,171 -2,088 -3,648
Non Operating Expenses
Interest Expense 3 4 4 5
Pre Tax Income 890 -2,115 -1,992 -3,521
Income Taxes — — — —
Minority Interest — — — —
Income Before Income Taxes — — — —
Net Income From Continuing Operations 890 -2,115 -1,992 -3,521
Net Income From Discontinued Operations — — — —
Net Income From Total Operations 890 -2,115 -1,992 -3,521
Non Recurring Events
Extraordinary Income Losses — — — —
Income From Cummulated Effect Of Accounting Changes — — — —
Income From Tax Loss Carryforward — — — —
Other Gains And Losses — — — —
Total Net Income 890 -2,115 -1,992 -3,521
Normalized Income 890 -2,115 -1,992 -3,521
NetIncome Available For Common 890 -2,115 -1,992 -3,521
Preferred Dividends — — — —
Excise Taxes — — — —